András Ladányi

4.5k total citations · 2 hit papers
26 papers, 3.5k citations indexed

About

András Ladányi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, András Ladányi has authored 26 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in András Ladányi's work include Molecular Biology Techniques and Applications (6 papers), Single-cell and spatial transcriptomics (4 papers) and Cancer Cells and Metastasis (4 papers). András Ladányi is often cited by papers focused on Molecular Biology Techniques and Applications (6 papers), Single-cell and spatial transcriptomics (4 papers) and Cancer Cells and Metastasis (4 papers). András Ladányi collaborates with scholars based in United States, Hungary and Germany. András Ladányi's co-authors include Ernst Lengyel, S. Diane Yamada, Hilary A. Kenny, Kristin M. Nieman, Carla Penicka, Iris L. Romero, Marion Zillhardt, Rebecca Buell‐Gutbrod, Marcus E. Peter and Katja Gwin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

András Ladányi

26 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth

2011 1.7k citations Kristin M. Nieman, Hilary A. Kenny et al. Nature Medicine profile →
Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis

2018 381 citations András Ladányi, Abir Mukherjee et al. Oncogene profile →

Peers

Countries citing papers authored by András Ladányi

Since Specialization

Citations

This map shows the geographic impact of András Ladányi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by András Ladányi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites András Ladányi more than expected).

Fields of papers citing papers by András Ladányi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by András Ladányi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by András Ladányi. The network helps show where András Ladányi may publish in the future.

Co-authorship network of co-authors of András Ladányi

This figure shows the co-authorship network connecting the top 25 collaborators of András Ladányi. A scholar is included among the top collaborators of András Ladányi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with András Ladányi. András Ladányi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Assessing ChatGPT's performance in answering common questions regarding endometrial cancer 2024 ·Gynecologic Oncology ·(unknown), (unknown), András Ladányi, Summer Dewdney	1
2	Development of an affordable, immersive model for robotic vaginal cuff closure: a randomized trial 2022 ·Journal of Robotic Surgery ·Federico Gheza, (unknown), (unknown), (unknown), Alberto Mangano, András Ladányi	3
3	Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis breakdown → 2018 ·Oncogene ·András Ladányi, Abir Mukherjee, Hilary A. Kenny, Alyssa E. Johnson, Anirban Mitra, Sinju Sundaresan, Kristin M. Nieman, Gloria Pascual, Salvador Aznar Benitah, Anthony Montag, S. Diane Yamada, Nada A. Abumrad, Ernst Lengyel	381
4	Expression of the Homeobox Gene HOXA9 in Ovarian Cancer Induces Peritoneal Macrophages to Acquire an M2 Tumor-Promoting Phenotype 2013 ·American Journal Of Pathology ·Song Yi Ko, András Ladányi, Ernst Lengyel, Honami Naora	59
5	HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts 2012 ·Journal of Clinical Investigation ·Song Yi Ko, Nicolas Barengo, András Ladányi, Ju‐Seog Lee, Frank C. Marini, Ernst Lengyel, Honami Naora	116
6	Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth breakdown → 2011 ·Nature Medicine ·Kristin M. Nieman, Hilary A. Kenny, Carla Penicka, András Ladányi, Rebecca Buell‐Gutbrod, Marion Zillhardt, Iris L. Romero, Mark Carey, Gordon B. Mills, Gökhan S. Hotamışlıgil, S. Diane Yamada, Marcus E. Peter, Katja Gwin, Ernst Lengyel	1707
7	Targeting the Urokinase Plasminogen Activator Receptor Inhibits Ovarian Cancer Metastasis 2010 ·Clinical Cancer Research ·Hilary A. Kenny, (unknown), András Ladányi, S. Diane Yamada, Anthony Montag, Hae Kyung Im, Sujatha Jagadeeswaran, David E. Shaw, Andrew P. Mazar, Ernst Lengyel	65
8	Subcutaneous Methylnaltrexone to Restore Postoperative Bowel Function in a Long-Term Opiate User 2010 ·International Journal of Gynecological Cancer ·András Ladányi, Sarah M. Temkin, Jonathan Moss	3
9	Case study of the morphologic variation of circulating tumor cells 2006 ·Human Pathology ·Dena Marrinucci, Kelly Bethel, Richard H. Bruce, Douglas N. Curry, B. R. Hsieh, Mark Humphrey, Robert T. Krivacic, Joan F. Kroener, Lindsay Kroener, András Ladányi, Nicole H. Lazarus, Jorge J. Nieva, Peter Kühn	126
10	Laser microdissection in translational and clinical research 2006 ·Cytometry Part A ·András Ladányi, Ferenc Sípos, Dominika Szőke, Orsolya Galamb, Béla Molnár, Zsolt Tulassay	22
11	High speed detection of circulating tumor cells 2006 ·Biosensors and Bioelectronics ·Huangpin B. Hsieh, Dena Marrinucci, Kelly Bethel, Douglas N. Curry, Mark Humphrey, Robert T. Krivacic, Joan F. Kroener, Lindsay Kroener, András Ladányi, Nicole H. Lazarus, Peter Kühn, Richard H. Bruce, Jorge J. Nieva	136
12	High-speed detection of occult tumor cells in peripheral blood 2005 ·PubMed ·Douglas N. Curry, Robert T. Krivacic, Huangpin B. Hsieh, András Ladányi, (unknown), Michael Ho, (unknown), Peter Kühn, Richard H. Bruce	4
13	Automated detection of immunofluorescently labeled cytomegalovirus‐infected cells in isolated peripheral blood leukocytes using decision tree analysis 2004 ·Cytometry Part A ·András Ladányi, Andrew C. Sher, Agneta Herlitz, (unknown), Stine‐Kathrein Kraeft, Jane Kepros, (unknown), David Ferguson, Marie L. Landry, Lan Bo Chen	4
14	A rare-cell detector for cancer 2004 ·Proceedings of the National Academy of Sciences ·Robert T. Krivacic, András Ladányi, Douglas N. Curry, Huangpin B. Hsieh, Peter Kühn, (unknown), Jane Kepros, (unknown), Michael Ho, Lan Bo Chen, Richard A. Lerner, Richard H. Bruce	274
15	Reliability of quantitative reverse-transcriptase-PCR-based detection of tumour cells in the blood between different laboratories using a standardised protocol 2003 ·European Journal of Cancer ·F A Vlems, András Ladányi, Ralf Gertler, Robert Rosenberg, J H S Diepstra, Christian Röder, H. Nekarda, Béla Péter Molnár, Zsolt Tulassay, Goos N.P. van Muijen, Ilka Vogel	19
16	Improved Indicators for Assessing the Reliability of Detection and Quantification by Kinetic PCR 2003 ·Clinical Chemistry ·Richie Soong, András Ladányi	18
17	Circulating tumor cells and serum tumor biomarkers in small cell lung cancer. 2003 ·PubMed ·C. Patrick, Lawrence S. Blaszkowsky, Ajit Bharti, András Ladányi, Stine‐Kathrein Kraeft, (unknown), Arthur T. Skarin, Lan Bo Chen, Ravi Salgia	36
18	Quantitative Reverse Transcription-PCR Comparison of Tumor Cell Enrichment Methods 2001 ·Clinical Chemistry ·András Ladányi, Richie Soong, (unknown), Béla Péter Molnár, Zsolt Tulassay	15
19	Circulating tumor cell clusters in the peripheral blood of colorectal cancer patients. 2001 ·PubMed ·Béla Molnár, András Ladányi, (unknown), L Sréter, Zsolt Tulassay	199
20	Detection of circulating tumor cell clusters in the peripheral blood of colorectal cancer patients 2000 ·Gastroenterology ·András Ladányi, Béla Molnár, (unknown), (unknown), Zsolt Tulassay	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact